Neuren Pharmaceuticals Ltd

NEW
FRA:NK9 (Australia)  
€ 10.7 +0.40 (+3.88%) Jul 31
77.12
P/B:
6.73
Market Cap:
€ 1.39B ($ 1.60B)
Enterprise V:
€ 1.21B ($ 1.40B)
Volume:
0
Avg Vol (2M):
1.61K
Trade In:

Neuren Pharmaceuticals Ltd (FRA:NK9) Dividend

Neuren Pharmaceuticals Ltd (FRA:NK9) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of 0.6%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:NK9 Dividend

Does Neuren Pharmaceuticals Ltd (FRA:NK9) pay a dividend?

Neuren Pharmaceuticals Ltd (FRA:NK9) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Neuren Pharmaceuticals Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Neuren Pharmaceuticals Ltd has returned capital to shareholders via buybacks at a rate of 0.6% over the past 3 years.

What are dividend-paying alternatives to Neuren Pharmaceuticals Ltd?

For dividend-paying alternatives in Neuren Pharmaceuticals Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.